In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Biolife Solutions Inc (NASDAQ: BLFS) closed at $17.19 in the last session, up 1.00% from day before closing price of $17.02. In other words, the price has increased by $1.00 from its previous closing price. On the day, 0.52 million shares were traded. BLFS stock price reached its highest trading level at $18.02 during the session, while it also had its lowest trading level at $16.9.
Ratios:
We take a closer look at BLFS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.83 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on April 04, 2024, initiated with a Buy rating and assigned the stock a target price of $22.
On July 11, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $29.
Oppenheimer Upgraded its Perform to Outperform on April 25, 2022, while the target price for the stock was maintained at $28.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 22 ’24 when Aebersold Sarah sold 410 shares for $16.50 per share. The transaction valued at 6,765 led to the insider holds 65,085 shares of the business.
Wichterman Troy sold 956 shares of BLFS for $14,636 on Apr 18 ’24. The Chief Financial Officer now owns 126,658 shares after completing the transaction at $15.31 per share. On Apr 18 ’24, another insider, Mathew Aby J., who serves as the EVP & Chief Scientific Officer of the company, sold 584 shares for $15.31 each. As a result, the insider received 8,941 and left with 319,098 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLFS now has a Market Capitalization of 778707008 and an Enterprise Value of 769702976. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.44 while its Price-to-Book (P/B) ratio in mrq is 2.30. Its current Enterprise Value per Revenue stands at 5.372 whereas that against EBITDA is -17.015.
Stock Price History:
Over the past 52 weeks, BLFS has reached a high of $24.50, while it has fallen to a 52-week low of $8.92. The 50-Day Moving Average of the stock is -1.17%, while the 200-Day Moving Average is calculated to be 12.11%.
Shares Statistics:
According to the various share statistics, BLFS traded on average about 374.87K shares per day over the past 3-months and 413920 shares per day over the past 10 days. A total of 45.17M shares are outstanding, with a floating share count of 43.16M. Insiders hold about 4.71% of the company’s shares, while institutions hold 100.98% stake in the company. Shares short for BLFS as of 1711584000 were 3198628 with a Short Ratio of 8.53, compared to 1709164800 on 3278551. Therefore, it implies a Short% of Shares Outstanding of 3198628 and a Short% of Float of 10.6800005.
